July 25, 2014 6:09 AM ET

Health Care Technology

Company Overview of Molecular Health AG

Company Overview

Molecular Health AG, a clinico-molecular informatics company, develops precision medicine by translating patient-specific molecular and genomic data, clinical history, and published scientific and medical evidence into drug choices for patients. The company offers clinico-molecular informatics solutions ranging from a drug safety assessment and prediction tool that analyzes the molecular basis of adverse events to a treatment decision support system that transforms genome sequences into evidence-based treatment strategies for cancer patients. Its solutions analyze and synthesize extensive bodies of molecular, biomedical, and clinical evidence; map results to a patient’s clinico-molecular sta...

Dufourstrasse 25

Basel,  4010


Founded in 2004


41 61 271 60 34


41 61 273 23 70

Key Executives for Molecular Health AG

Chief Executive Officer
Age: 70
Founder and Chairman
Age: 52
Senior Vice President of Finance
Age: 41
Chief Operating Officer and Executive Vice President
Compensation as of Fiscal Year 2014.

Molecular Health AG Key Developments

MolecularHealth Appoints Gabriel Bien-Willner as Medical Director for U.S. Next-Generation Sequencing Lab

MolecularHealth announced the appointment of Gabriel Bien-Willner as medical director of its CLIA-certified next-generation sequencing lab in The Woodlands, Texas. Dr. Bien-Willner will report to Chief Medical Officer Dr. Shelly Gunn and manage the day-to-day clinical duties of the laboratory. Dr. Bien-Willner has expertise in genetics and genomics, next-generation sequencing technology and pipeline design.

MolecularHealth Launches MolecularHealth COPE

MolecularHealth announced the official launch of MolecularHealth COPE (Corporate Oncology Program for Employers), powered by its cancer treatment decision support offering, TreatmentMAP. COPE enables self-funded employers to offer access to TreatmentMAP to their employees via a pre-packaged offering, which includes materials for employees, as well as working closely with patients' physicians through the process of testing, analyzing and receiving results. SAP is working with MolecularHealth to become one of the first organizations to provide its employees with access to COPE and plans to offer it in the third quarter of 2014. SAP technology also plays a role in enabling COPE; the SAP Genomic Analyzer solution running on the SAP HANA platform is used in an early adoption phase to speed up the genome alignment process by a factor of 300 compared to previously used algorithms. TreatmentMAP generates an individual tumor analysis for each patient and then provides a clinical interpretation of the genomic patient data to support the patient's physician in making an individualized treatment decision. Based on a proprietary analytics engine, TreatmentMAP leverages the results of next generation sequencing (NGS) genetic testing. Now, for the first time and in a clear and understandable way, physicians and individuals diagnosed with cancer will have access to actionable information to guide the selection of cancer treatments. The TreatmentMAP offering, available from MolecularHealth offices in the United States and in Europe, is accessible to all patients diagnosed with solid tumor cancer, regardless of where they live.

MolecularHealth Announces the Appointment of Waun Ki Hong to Advisory Board

MolecularHealth announced Waun Ki Hong, M.D., as the newest member of its advisory board. Dr. Hong is one of the nation’s experts on head, neck and lung cancers. Currently, Dr. Hong serves as the head of the cancer medicine division at the University of Texas MD Anderson Cancer Center. He is also an American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine, professor of thoracic/head and neck medical oncology, and former president of the American Association for Cancer Research.

Similar Private Companies By Industry

Company Name Region
Ascendys Sarl Europe
Fitonic AG Europe
Sanovation AG Europe
EBD Group AG Europe
vision4health Laufenberg & Co. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Molecular Health AG, please visit www.molecularhealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.